The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_001369369.1(FOXN1):c.1135+20G>A

CA8459444

1127854 (ClinVar)

Gene: FOXN1
Condition: T-cell immunodeficiency, congenital alopecia, and nail dystrophy
Inheritance Mode: Semidominant inheritance
UUID: 69b404c6-a68c-4586-972b-fffa31853d5d
Approved on: 2024-07-29
Published on: 2024-07-29

HGVS expressions

NM_001369369.1:c.1135+20G>A
NM_001369369.1(FOXN1):c.1135+20G>A
NC_000017.11:g.28534558G>A
CM000679.2:g.28534558G>A
NC_000017.10:g.26861576G>A
CM000679.1:g.26861576G>A
NC_000017.9:g.23885703G>A
NG_007260.1:g.15618G>A
ENST00000577936.2:c.1135+20G>A
ENST00000579795.6:c.1135+20G>A
ENST00000226247.2:c.1135+20G>A
ENST00000481916.6:c.*1195+69493C>T
ENST00000579795.5:c.1135+20G>A
NM_003593.2:c.1135+20G>A
NM_003593.3:c.1135+20G>A
More

Likely Benign

Met criteria codes 2
BP4 BP7
Not Met criteria codes 2
BS1 PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Severe Combined Immunodeficiency Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for FOXN1 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Severe Combined Immunodeficiency Disease VCEP
NM_001369369.1(FOXN1):c.1135+20G>A is an intronic variant. SpliceAI predicts no impact to the splice consensus sequence nor the creation of a new splice site (delta scores 0.00) and the nucleotide is not highly conserved (phyloP score -0.235) (BP4, BP7). In summary this variant meets criteria to be classified as likely benign for semidominant T-cell immunodeficiency, congenital alopecia, and nail dystrophy due to FOXN1 deficiency based on the ACMG/AMP criteria applied: BP4 and BP7 as specified by the ClinGen SCID VCEP FOXN1 subgroup.
Met criteria codes
BP4
SpliceAI predicts no impact to the splice consensus sequence nor the creation of a new splice site (delta scores 0.00).
BP7
SpliceAI predicts no impact to the splice consensus sequence nor the creation of a new splice site (delta scores 0.00) and the nucleotide is not highly conserved (phyloP score -0.235).
Not Met criteria codes
BS1
The variant occurs at an allele frequency between the BS1 (>0.00141) and PM2 (<0.00002412) thresholds, with a gnomADv4.0 GrpMax filtering AF of 0.001095 based on 1352/1179186 alleles in the European (non-Finnish) population. Note the Middle Eastern population has a MAF of 0.002502 but that is not considered for BS1 due to the higher incidence of SCID in this bottle-necked population.
PM2
The variant occurs at an allele frequency between the BS1 (>0.00141) and PM2 (<0.00002412) thresholds, with a gnomADv4.0 GrpMax filtering AF of 0.001095 based on 1352/1179186 alleles in the European (non-Finnish) population. Additionally a homozygote is present in the Admixed American population.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.